The DOI matches its Crossref record; 179 of the 179 references it cites were found in a registry or an index.
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia
Open accessAbstract
Based on the recent literature and collective experience, an international consortium developed revised guidelines for the diagnosis of behavioural variant frontotemporal dementia. The validation process retrospectively reviewed clinical records and compared the sensitivity of proposed and earlier criteria in a multi-site sample of patients with pathologically verified frontotemporal lobar degeneration. According to the revised criteria, 'possible' behavioural variant frontotemporal dementia requires three of six clinically discriminating features (disinhibition, apathy/inertia, loss of sympathy/empathy, perseverative/compulsive behaviours, hyperorality and dysexecutive neuropsychological profile). 'Probable' behavioural variant frontotemporal dementia adds functional disability and characteristic neuroimaging, while behavioural variant frontotemporal dementia 'with definite frontotemporal lobar degeneration' requires histopathological confirmation or a pathogenic mutation. Sixteen brain banks contributed cases meeting histopathological criteria for frontotemporal lobar degeneration and a clinical diagnosis of behavioural variant frontotemporal dementia, Alzheimer's disease, dementia with Lewy bodies or vascular dementia at presentation. Cases with predominant primary progressive aphasia or extra-pyramidal syndromes were excluded. In these autopsy-confirmed cases, an experienced neurologist or psychiatrist ascertained clinical features necessary for making a diagnosis according to previous and proposed criteria at presentation. Of 137 cases where features were available for both proposed and previously established criteria, 118 (86%) met 'possible' criteria, and 104 (76%) met criteria for 'probable' behavioural variant frontotemporal dementia. In contrast, 72 cases (53%) met previously established criteria for the syndrome (P < 0.001 for comparison with 'possible' and 'probable' criteria). Patients who failed to meet revised criteria were significantly older and most had atypical presentations with marked memory impairment. In conclusion, the revised criteria for behavioural variant frontotemporal dementia improve diagnostic accuracy compared with previously established criteria in a sample with known frontotemporal lobar degeneration. Greater sensitivity of the proposed criteria may reflect the optimized diagnostic features, less restrictive exclusion features and a flexible structure that accommodates different initial clinical presentations. Future studies will be needed to establish the reliability and specificity of these revised diagnostic guidelines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Frontotemporal dementia is caused by frontotemporal lobar degeneration (FTLD), which features abnormal aggregation of the microtubule associated protein consisting of tau (FTLD-tau) or the transactivating DNA-binding protein 43.16,18–20”
From Association of Cognitive and Behavioral Features Between Adults With Tuberous Sclerosis and Frontotemporal Dementia (2020) · cites this paper as [19]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In bvFTD, language dysfunction is initially absent, unlike other frontotemporal dementia phenotypes, namely progressive nonfluent aphasia and semantic dementia [17].”
From Diagnosing the frontal variant of Alzheimer’s disease: a clinician’s yellow brick road (2017) · cites this paper as [17]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“To ensure the generalizability of the results, the machine learning model was trained on a mainly sporadic cohort and tested in a held-out population of genetic bvFTD, therefore relying on one of the gold standards for diagnosis (i.e., definite bvFTD). 7”
From MRI data-driven algorithm for the diagnosis of behavioural variant frontotemporal dementia (2021) · cites this paper as [7]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The performance of our classifier is superior than the performance reported in several articles that have analyzed the standard diagnostic methods currently used in the clinical practice.”
From MRI data-driven algorithm for the diagnosis of behavioural variant frontotemporal dementia (2021) · cites this paper as [7]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Within a pathology-confirmed cohort, the sensitivity reported for the revised diagnostic criteria for bvFTD was 86% for possible diagnosis and 75% for probable bvFTD (with neuroimaging support). 7”
From MRI data-driven algorithm for the diagnosis of behavioural variant frontotemporal dementia (2021) · cites this paper as [7]
Experimental — accuracy not yet measured
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“All patients (n = 96) were clinically evaluated by expert neurologists (M.G., D.J.I.) at the time of recording at the frontotemporal degeneration center (FTDC) in the neurology department of the Hospital of the University of Pennsylvania, and they were classified at a weekly consensus meeting at the FTDC using established clinical criteria.”
From Automatic classification of AD pathology in FTD phenotypes using natural speech (2024) · cites this paper as [27]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“the atrophy of specific brain regions shown by structural MRI is an important part of the diagnostic criteria for FTD and AD (McKhann et al., 2011; Rascovsky et al., 2011)”
From Deep Learning-Based Classification and Voxel-Based Visualization of Frontotemporal Dementia and Alzheimer's Disease (2021) · cites this paper as Rascovsky et al., 2011
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Based on these criteria, a degree of probability of underlying frontotemporal lobar degeneration can be attributed to cases presenting with at least three of five behavioural criteria and one cognitive criterion.”
From Advances and controversies in frontotemporal dementia: diagnosis, biomarkers, and therapeutic considerations (2022) · cites this paper as [3]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The clinical diagnosis of behavioural variant frontot emporal dementia is based on consensus diagnostic criteria that have been derived from an international cohort of 406 pathologically verified cases of frontotemporal dementia.3”
From Advances and controversies in frontotemporal dementia: diagnosis, biomarkers, and therapeutic considerations (2022) · cites this paper as [3]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Atrophy in the frontal or temporal lobes, which can be either symmetrical or very focal or asymmetrical, supports the clinical suspicion of frontotemporal dementia.3,4”
From Advances and controversies in frontotemporal dementia: diagnosis, biomarkers, and therapeutic considerations (2022) · cites this paper as [3]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“lack of support is more concerning for these carers especially when behavioural symptoms are severe (Gorno-Tempini et al. , 2011; Rascovsky et al. , 2011)”
From Which interventions work for dementia family carers?: an updated systematic review of randomized controlled trials of carer interventions. (2018) · cites this paper as Rascovsky et al., 2011
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Contrary to popular belief, executive dysfunction is not always the most prominent deficit in bvFTD and may not even be present on formal neuropsychological test results in the early stages (Pachana et al. , 1996; Kipps et al. , 2008; Rascovsky et al. , 2011).”
From Recommendations to distinguish behavioural variant frontotemporal dementia from psychiatric disorders (2020) · cites this paper as Rascovsky et al. , 2011
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The presence of pathological atrophy in frontal or anterior temporal areas increases the bvFTD diagnostic certainty from 'possible' to 'probable' in current diagnostic criteria (Rascovsky et al. , 2011), which increases the specificity from 82% to 95% (Harris et al. , 2013).”
From Recommendations to distinguish behavioural variant frontotemporal dementia from psychiatric disorders (2020) · cites this paper as Rascovsky et al. , 2011
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In addition, many of the DSM-5 specific dementia categories have separate criteria sets for 'Probable' and 'Possible' , which in most cases have been adapted from the neurological literature 88-91 .”
From An organization‐ and category‐level comparison of diagnostic requirements for mental disorders in ICD ‐11 and DSM ‐5 (2021) · cites this paper as [91]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“While semantic (category) fluency is usually impaired to a greater degree in fvAD, phonemic (letter) fluency is more affected in bvFTD [17].”
From Diagnosing the frontal variant of Alzheimer’s disease: a clinician’s yellow brick road (2017) · cites this paper as [17]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The clinical diagnosis of bvFTD is currently based on the presence of behavioral changes antedating cognitive deficits with a sensitivity of 76–95% and specificity of 82–95% [16, 17].”
From Diagnosing the frontal variant of Alzheimer’s disease: a clinician’s yellow brick road (2017) · cites this paper as [17]
Experimental — accuracy not yet measuredIn the citing paper
“Frontotemporal dementia (FTD) is a neurodegenerative disorder that predominantly affects the frontal and/or temporal lobes and presents with a spectrum of social, behavioral, language, psychiatric, and motor problems. 1 , 2 , 3”
From Clinical recognition of frontotemporal dementia with right anterior temporal predominance: A multicenter retrospective cohort study (2024) · cites this paper as [2]
In the citing paper
“The development of the DSM-5 criteria for the various subtypes involved extensive discussions with experts from diverse fields to harmonize the DSM criteria with criteria developed by other expert groups, such as the NIA-AA, 20,27 the frontotemporal dementia expert group, 28,29 the consortium on DLB, 30 the VASCOG working group, 31 the Movement Disorder Study Task Force on Parkinson Disease 32 and”
From Classifying neurocognitive disorders: the DSM-5 approach (2014) · cites this paper as [29]
In the citing paper
“These criteria are consistent with those published by external expert groups, 28,29 but it must be pointed out that the identification of frontotemporal degeneration as the aetiology for mild neurocognitive disorder in the absence of genetic and/or neuroimaging evidence is not yet established.”
From Classifying neurocognitive disorders: the DSM-5 approach (2014) · cites this paper as [29]
In the citing paper
“Second, patients received diagnoses based on established clinical criteria only,37,38 without testing for ATN biomarkers in AD such as the deposition of amyloid-β and tau proteins established via Positron Emission Tomography, CSF, or plasma in AD.94, 95, 96, 97”
From Altered spatiotemporal brain dynamics of interoception in behavioural-variant frontotemporal dementia (2025) · cites this paper as [37]
In the citing paper
“The diagnosis was concluded in a multidisciplinary meeting using consensus criteria for probable FTD, PPD (DSM-V), and AD [25,31,32].”
In the citing paper
“Final diagnoses were based on internationally established criteria [12, 46, 49–52].”
In the citing paper
“Two reviewers (JF and DP) evaluated the overall methodological quality of the full text papers taking into account eligibility criteria of (I) high diagnostic accuracy [i.e., probable or definite bvFTD by international diagnostic criteria (Rascovsky et al., 2011)]; (II) sample size; (III) follow-up time; (IIII) use of appropriate outcome measures, when weighing research evidence.”
From The pursuit for markers of disease progression in behavioral variant frontotemporal dementia: a scoping review to optimize outcome measures for clinical trials (2024) · cites this paper as Rascovsky et al., 2011
In the citing paper
“In current international diagnostic criteria, the cognitive profile of bvFTD is characterized by executive deficits, with relative sparing of memory and visuospatial functioning (Rascovsky et al., 2011).”
From The pursuit for markers of disease progression in behavioral variant frontotemporal dementia: a scoping review to optimize outcome measures for clinical trials (2024) · cites this paper as Rascovsky et al., 2011
In the citing paper
“Since bvFTD is marked by typical frontal and (anterior) temporal atrophy, hypometabolism or hypoperfusion (Rascovsky et al., 2011), the use of neuroimaging offers an essential measure of disease progression.”
From The pursuit for markers of disease progression in behavioral variant frontotemporal dementia: a scoping review to optimize outcome measures for clinical trials (2024) · cites this paper as Rascovsky et al., 2011
In the citing paper
“A logopenic variant of PPA (lvPPA) has also been described, but is usually associated with AD pathology.”
From New developments of biofluid‐based biomarkers for routine diagnosis and disease trajectories in frontotemporal dementia (2022) · cites this paper as [5]
In the citing paper
“In current clinical practice, the place of CSF analysis is to exclude AD pathology and verify neurodegeneration—it does not have utility for affirmative diagnosis of FTD. 5”
From New developments of biofluid‐based biomarkers for routine diagnosis and disease trajectories in frontotemporal dementia (2022) · cites this paper as [5]
In the citing paper
“Clinically, bvFTD is characterised by profound changes to behaviour and personality, with early brain atrophy observed in the ventromedial prefrontal cortex and insula (Rascovsky et al., 2011), extending to the temporal lobes and subcortical regions with disease progression (Landin-Romero et al., 2017).”
From Thinking versus feeling: How interoception and cognition influence emotion recognition in behavioural-variant frontotemporal dementia, Alzheimer's disease, and Parkinson's disease (2023) · cites this paper as Rascovsky et al., 2011
In the citing paper
“Diagnosis was established by the multidisciplinary teams at each research institute based on current consensus diagnostic criteria (McKhann et al., 2011; Postuma et al., 2015; Rascovsky et al., 2011).”
From Thinking versus feeling: How interoception and cognition influence emotion recognition in behavioural-variant frontotemporal dementia, Alzheimer's disease, and Parkinson's disease (2023) · cites this paper as Rascovsky et al., 2011
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hirono, N., Mori, E., Ikejiri, Y., Imamura, T., Shimomura, T., Hashimoto, M., Yamashita, H., & Ikeda, M. (1997) · PubMed · Cited by 21,012
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
Self-citationAmyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia
Cummings, J. L., Mega, M., Gray, K., Rosenberg-Thompson, S., Carusi, D. A., & Gornbein, J. (1994) · Neurology · doi:10.1212/wnl.44.12.2308 · Cited by 7,568 · cited 1×
“For quantification of these behaviours, scales such as the Neuropsychiatric Inventory (Cummings et al., 1994), the Cambridge Behavioural Inventory (Bozeat et al., 2000; Wedderburn et al., 2008) or the Frontal Behavioural Inventory (Kertesz et al., 2000) are available to guide behavioural ratings.”
MethodClassification of primary progressive aphasia and its variants
Gorno-Tempini, M. L., Hillis, A. E., Weintraub, S., Kertesz, A., Mendez, M., Cappa, S. F., Ogar, J. M., Rohrer, J. D., Black, S., Boeve, B. F., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e31821103e6 · Cited by 5,141
Self-citationFrontotemporal lobar degeneration: A consensus on clinical diagnostic criteria
Neary, D., Snowden, J. S., Gustafson, L., Passant, U., Stuss, D., Black, S., Freedman, M., Kertesz, A., Robert, P. H., Albert, M., et al. (1998) · Neurology · doi:10.1212/wnl.51.6.1546 · Cited by 5,047
Self-citationThe FAB: A frontal assessment battery at bedside
Dubois, B., Slachevsky, A., Litvan, I., & Pillon, B. (2000) · Neurology · doi:10.1212/wnl.55.11.1621 · Cited by 3,913
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498
Measurement of Functional Activities in Older Adults in the Community
PFEFFER, R. I., Kurosaki, T., Harrah, C. H., Chance, J. M., & Filos, S. (1982) · Journal of Gerontology · doi:10.1093/geronj/37.3.323 · Cited by 2,978
Flagged first, then by citations
Research works printed but not linked: 1
- Rascovsky, 2007, Inter-rater reliability of diagnostic criteria for Frontotemporal Dementia (FTD): Findings from the California Non-AD Diagnostic Reliability Consortium, Neurology, 68, A354
Cited by
Sorted by citations
Items 201–300 of 355
Remnestål, J., Öijerstedt, L., Ullgren, A., Olofsson, J., Bergström, S., Kultima, K., Ingelsson, M., Kilander, L., Uhlén, M., Månberg, A., et al. (2020) · Translational Neurodegeneration · doi:10.1186/s40035-020-00198-y · Cited by 56
Wei, G., Irish, M., Hodges, J. R., Piguet, O., & Kumfor, F. (2020) · Journal of Neurology · doi:10.1007/s00415-019-09679-1 · Cited by 54
Self-citationSedeño, L., Piguet, O., Abrevaya, S., Desmaras, H., García‐Cordero, I., Baez, S., Alethia de la Fuente, L., Reyes, P., Tu, S., Moguilner, S., et al. (2017) · Human Brain Mapping · doi:10.1002/hbm.23627 · Cited by 55
Self-citationPhenocopy syndrome of behavioral variant frontotemporal dementia: a systematic review
Valente, E. S., Caramelli, P., Gambogi, L. B., Mariano, L. I., Guimarães, H. C., Teixeira, A. L., & de Souza, L. C. (2019) · Alzheimer's Research & Therapy · doi:10.1186/s13195-019-0483-2 · Cited by 54
Educational disparities in brain health and dementia across Latin America and the United States
Gonzalez‐Gomez, R., Legaz, A., Moguilner, S., Cruzat, J., Hernández, H., Baez, S., Cocchi, R., Coronel‐Olivero, C., Medel, V., Tagliazuchi, E., et al. (2024) · Alzheimer's & Dementia · doi:10.1002/alz.14085 · Cited by 55
Self-citationDistinct populations of highly potent TAU seed conformers in rapidly progressing Alzheimer’s disease
Kim, C., Haldiman, T., Kang, S.-G., Hromadkova, L., Han, Z. Z., Chen, W., Lissemore, F., Lerner, A., de Silva, R., Cohen, M. L., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abg0253 · Cited by 55
FTD spectrum: Neuroimaging across the FTD spectrum
Whitwell, J. L. (2019) · Progress in Molecular Biology and Translational Science · doi:10.1016/bs.pmbts.2019.05.009 · Cited by 53
del Campo, M., Zetterberg, H., Gandy, S., Onyike, C. U., Oliveira, F., Udeh‐Momoh, C., Lleó, A., Teunissen, C. E., & Pijnenburg, Y. (2022) · Alzheimer's & Dementia · doi:10.1002/alz.12643 · Cited by 52
Self-citationTong, T., Ledig, C., Guerrero, R., Schuh, A., Koikkalainen, J., Tolonen, A., Rhodius, H., Barkhof, F., Tijms, B., Lemstra, A. W., et al. (2017) · NeuroImage: Clinical · doi:10.1016/j.nicl.2017.06.012 · Cited by 54
Toward the Automation of Diagnostic Conversation Analysis in Patients with Memory Complaints
Mirheidari, B., Blackburn, D., Harkness, K., Walker, T., Venneri, A., Reuber, M., & Christensen, H. (2017) · Journal of Alzheimer’s Disease · doi:10.3233/jad-160507 · Cited by 54
Motor speech signature of behavioral variant frontotemporal dementia: Refining the phenotype
Vogel, A. P., Poole, M. L., Pemberton, H., Caverlé, M. W. J., Boonstra, F. M. C., Low, E., Darby, D., & Brodtmann, A. (2017) · Neurology · doi:10.1212/wnl.0000000000004248 · Cited by 49
Cerebrospinal fluid biomarkers predict frontotemporal dementia trajectory
Ljubenkov, P. A., Staffaroni, A. M., Rojas, J. C., Allen, I. E., Wang, P., Heuer, H., Karydas, A., Kornak, J., Cobigo, Y., Seeley, W. W., et al. (2018) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.643 · Cited by 49
Self-citationAdvances in treatment of frontotemporal dementia
Magrath Guimet, N., Zapata-Restrepo, L. M., & Miller, B. L. (2022) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/appi.neuropsych.21060166 · Cited by 52
Self-citationSynaptic Loss in Frontotemporal Dementia Revealed by [ 11 C ] UCB‐J Positron Emission Tomography
Malpetti, M., Jones, P. S., Cope, T. E., Holland, N., Naessens, M., Rouse, M. A., Rittman, T., Savulich, G., Whiteside, D. J., Street, D., et al. (2023) · Annals of Neurology · doi:10.1002/ana.26543 · Cited by 53
Neuropsychological differentiation of progressive aphasic disorders
Harris, J. M., Saxon, J. A., Jones, M., Snowden, J. S., & Thompson, J. C. (2019) · Journal of Neuropsychology · doi:10.1111/jnp.12149 · Cited by 47
Jastorff, J., De Winter, F., Van den Stock, J., Vandenberghe, R., Giese, M. A., & Vandenbulcke, M. (2016) · Human Brain Mapping · doi:10.1002/hbm.23322 · Cited by 46
Schievink, W. I., Maya, M. M., Barnard, Z. R., Moser, F. G., Jean-Pierre, S., Waxman, A. D., & Nuño, M. (2018) · Operative Neurosurgery · doi:10.1093/ons/opy029 · Cited by 51
Gossink, F., Schouws, S., Krudop, W., Scheltens, P., Stek, M., Pijnenburg, Y., & Dols, A. (2018) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2017.12.008 · Cited by 49
Self-citationFalgàs, N., Sánchez-Valle, R., Bargalló, N., Balasa, M., Fernández-Villullas, G., Bosch, B., Olives, J., Tort-Merino, A., Antonell, A., Muñoz-García, C., et al. (2019) · NeuroImage: Clinical · doi:10.1016/j.nicl.2019.101927 · Cited by 47
GABAergic cortical network physiology in frontotemporal lobar degeneration
Adams, N. E., Hughes, L. E., Rouse, M. A., Phillips, H. N., Shaw, A. D., Murley, A. G., Cope, T. E., Bevan-Jones, W. R., Passamonti, L., Street, D., et al. (2021) · Brain · doi:10.1093/brain/awab097 · Cited by 47
Personalized risk for clinical progression in cognitively normal subjects-the ABIDE project
Initiative, F. T. A. D. N., van Maurik, I. S., Slot, R. E. R., Verfaillie, S. C. J., Zwan, M. D., Bouwman, F. H., Prins, N. D., Teunissen, C. E., Scheltens, P., Barkhof, F., et al. (2019) · Alzheimer's Research & Therapy · doi:10.1186/s13195-019-0487-y · Cited by 47
Ash, S., Nevler, N., Phillips, J., Irwin, D. J., McMillan, C. T., Rascovsky, K., & Grossman, M. (2019) · Brain and Language · doi:10.1016/j.bandl.2019.04.006 · Cited by 47
Self-citationMcCarthy, J., Collins, D. L., & Ducharme, S. (2018) · NeuroImage: Clinical · doi:10.1016/j.nicl.2018.08.028 · Cited by 47
Heuer, H. W., Wang, P., Rascovsky, K., Wolf, A., Appleby, B., Bove, J., Bordelon, Y., Brannelly, P., Brushaber, D. E., Caso, C., et al. (2020) · Alzheimer's & Dementia · doi:10.1002/alz.12046 · Cited by 43
Self-citationVijverberg, E. G. B., Dols, A., Krudop, W. A., Del Campo Milan, M., Kerssens, C. J., Gossink, F., Prins, N. D., Stek, M. L., Scheltens, P., Teunissen, C. E., et al. (2017) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1016/j.dadm.2017.01.009 · Cited by 46
Self-citationSynaptic density in carriers of C9orf72 mutations: a [11C]UCB‐J PET study
Malpetti, M., Holland, N., Jones, P. S., Ye, R., Cope, T. E., Fryer, T. D., Hong, Y. T., Savulich, G., Rittman, T., Passamonti, L., et al. (2021) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51407 · Cited by 44
Ulugut, H., Bertoux, M., Younes, K., Montembeault, M., Fumagalli, G. G., Samanci, B., Illán‐Gala, I., Kuchcinski, G., Leroy, M., Thompson, J. C., et al. (2024) · Alzheimer's & Dementia · doi:10.1002/alz.14076 · Cited by 43
Self-citationHuynh, K., Piguet, O., Kwok, J., Dobson-Stone, C., Halliday, G. M., Hodges, J. R., & Landin-Romero, R. (2021) · Neurology · doi:10.1212/wnl.0000000000011638 · Cited by 43
Self-citationSantacruz Escudero, J. M., Beltrán, J., Palacios, Á., Chimbí, C. M., Matallana, D., Reyes, P., Perez-Sola, V., & Santamaría-García, H. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00176 · Cited by 41
Early symptoms in symptomatic and preclinical genetic frontotemporal lobar degeneration
Tavares, T. P., Mitchell, D. G. V., Coleman, K. K., Coleman, B. L., Shoesmith, C. L., Butler, C. R., Santana, I., Danek, A., Gerhard, A., de Mendonca, A., et al. (2020) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2020-322987 · Cited by 39
Self-citationIn vivo PET imaging of neuroinflammation in familial frontotemporal dementia
Malpetti, M., Rittman, T., Jones, P. S., Cope, T. E., Passamonti, L., Bevan-Jones, W. R., Patterson, K., Fryer, T. D., Hong, Y. T., Aigbirhio, F. I., et al. (2021) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2020-323698 · Cited by 43
Vijverberg, E. G. B., Dols, A., Krudop, W. A., Peters, A., Kerssens, C. J., van Berckel, B. N. M., Wattjes, M. P., Barkhof, F., Gossink, F., Prins, N. D., et al. (2016) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000444849 · Cited by 40
Self-citationJiskoot, L. C., Poos, J. M., Vollebergh, M. E., Franzen, S., van Hemmen, J., Papma, J. M., van Swieten, J. C., Kessels, R. P. C., & van den Berg, E. (2021) · Journal of Neurology · doi:10.1007/s00415-020-10096-y · Cited by 42
Cerebrospinal fluid α‐synuclein contributes to the differential diagnosis of Alzheimer's disease
Shi, M., Tang, L., Toledo, J. B., Ginghina, C., Wang, H., Aro, P., Jensen, P. H., Weintraub, D., Chen‐Plotkin, A. S., Irwin, D. J., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.015 · Cited by 42
Self-citationDucharme, S., Pearl-Dowler, L., Gossink, F., McCarthy, J., Lai, J., Dickerson, B. C., Chertkow, H., Rapin, L., Vijverberg, E., Krudop, W., et al. (2019) · Journal of Alzheimer's Disease · doi:10.3233/jad-180839 · Cited by 42
Self-citationAutomated analysis of lexical features in frontotemporal degeneration
Cho, S., Nevler, N., Ash, S., Shellikeri, S., Irwin, D. J., Massimo, L., Rascovsky, K., Olm, C., Grossman, M., & Liberman, M. (2021) · Cortex · doi:10.1016/j.cortex.2021.01.012 · Cited by 41
Self-citationRevised Self-Monitoring Scale: A potential endpoint for frontotemporal dementia clinical trials
Toller, G., Ranasinghe, K., Cobigo, Y., Staffaroni, A., Appleby, B., Brushaber, D., Coppola, G., Dickerson, B., Domoto-Reilly, K., Fields, J., et al. (2020) · Neurology · doi:10.1212/wnl.0000000000009451 · Cited by 40
Self-citationVisuospatial dysfunction in Alzheimer's disease and behavioural variant frontotemporal dementia
Salimi, S., Irish, M., Foxe, D., Hodges, J. R., Piguet, O., & Burrell, J. R. (2019) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2019.04.019 · Cited by 40
Self-citationDiagnosing the frontal variant of Alzheimer’s disease: a clinician’s yellow brick road
Sawyer, R. P., Rodriguez-Porcel, F., Hagen, M., Shatz, R., & Espay, A. J. (2017) · Journal of Clinical Movement Disorders · doi:10.1186/s40734-017-0052-4 · Cited by 40
“While semantic (category) fluency is usually impaired to a greater degree in fvAD, phonemic (letter) fluency is more affected in bvFTD [17].”
BackgroundHazelton, J. L., Fittipaldi, S., Fraile-Vazquez, M., Sourty, M., Legaz, A., Hudson, A. L., Cordero, I. G., Salamone, P. C., Yoris, A., Ibañez, A., et al. (2023) · Cortex · doi:10.1016/j.cortex.2023.02.009 · Cited by 39
Self-citationSogorb-Esteve, A., Nilsson, J., Swift, I. J., Heller, C., Bocchetta, M., Russell, L. L., Peakman, G., Convery, R. S., van Swieten, J. C., Seelaar, H., et al. (2022) · Alzheimer's Research & Therapy · doi:10.1186/s13195-022-01042-3 · Cited by 39
Self-citationLongitudinal memory profiles in behavioral-variant frontotemporal dementia and Alzheimer’s disease
Schubert, S., Leyton, C. E., Hodges, J. R., & Piguet, O. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-150802 · Cited by 37
Self-citationAtypical Alzheimer Disease Variants
Polsinelli, A. J., & Apostolova, L. G. (2022) · Continuum · doi:10.1212/con.0000000000001082 · Cited by 39
What Do We Mean by Behavioral Disinhibition in Frontotemporal Dementia?
Magrath Guimet, N., Miller, B. L., Allegri, R. F., & Rankin, K. P. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.707799 · Cited by 38
Self-citationLiew, T. M. (2021) · Age and Ageing · doi:10.1093/ageing/afab044 · Cited by 38
Devenney, E., Swinn, T., Mioshi, E., Hornberger, M., Dawson, K. E., Mead, S., Rowe, J. B., & Hodges, J. R. (2018) · BMC Neurology · doi:10.1186/s12883-018-1060-1 · Cited by 37
Self-citationSha, S. J., Miller, Z. A., Min, S., Zhou, Y., Brown, J., Mitic, L. L., Karydas, A., Koestler, M., Tsai, R., Corbetta‐Rastelli, C., et al. (2017) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2017.08.002 · Cited by 36
Self-citationProgranulin as a candidate biomarker for therapeutic trial in patients with ALS and FTLD
Feneberg, E., Steinacker, P., Volk, A. E., Weishaupt, J. H., Wollmer, M. A., Boxer, A., Tumani, H., Ludolph, A. C., & Otto, M. (2016) · Journal of Neural Transmission · doi:10.1007/s00702-015-1486-1 · Cited by 36
Chu, M., Wen, L., Jiang, D., Liu, L., Nan, H., Yue, A., Wang, Y., Wang, Y., Qu, M., Wang, N., et al. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02746-5 · Cited by 33
Al-Hameed, S., Benaissa, M., Christensen, H., Mirheidari, B., Blackburn, D., & Reuber, M. (2019) · PLOS ONE · doi:10.1371/journal.pone.0217388 · Cited by 37
Carandini, T., Arighi, A., Sacchi, L., Fumagalli, G. G., Pietroboni, A. M., Ghezzi, L., Colombi, A., Scarioni, M., Fenoglio, C., De Riz, M. A., et al. (2019) · Alzheimer's Research & Therapy · doi:10.1186/s13195-019-0543-7 · Cited by 36
Bolsewig, K., Hok-A-Hin, Y. S., Sepe, F. N., Boonkamp, L., Jacobs, D., Bellomo, G., Paoletti, F. P., Vanmechelen, E., Teunissen, C. E., Parnetti, L., et al. (2022) · Journal of Alzheimer's Disease · doi:10.3233/jad-220318 · Cited by 36
Psychosis in behavioral variant frontotemporal dementia
Gossink, F. T., Vijverberg, E. G., Krudop, W., Scheltens, P., Stek, M. L., Pijnenburg, Y. A., & Dols, A. (2017) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s127863 · Cited by 36
Self-citationAbrevaya, S., Fittipaldi, S., García, A. M., Dottori, M., Santamaria-Garcia, H., Birba, A., Yoris, A., Hildebrandt, M. K., Salamone, P., De la Fuente, A., et al. (2020) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000868 · Cited by 34
Multimodal mechanisms of human socially reinforced learning across neurodegenerative diseases
Legaz, A., Abrevaya, S., Dottori, M., González Campo, C., Birba, A., Martorell Caro, M., Aguirre, J., Slachevsky, A., Aranguiz, R., Serrano, C., et al. (2022) · Brain · doi:10.1093/brain/awab345 · Cited by 34
Kamath, V., Chaney, G.-A. S., DeRight, J., & Onyike, C. U. (2019) · Psychological Medicine · doi:10.1017/s0033291718003604 · Cited by 35
Self-citationTan, K. S., Libon, D. J., Rascovsky, K., Grossman, M., & Xie, S. X. (2013) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e31827bdc6f · Cited by 36
Self-citationPharmacotherapy for Neuropsychiatric Symptoms in Frontotemporal Dementia
Le, C., & Finger, E. (2021) · CNS Drugs · doi:10.1007/s40263-021-00854-5 · Cited by 26
Deep grading for MRI-based differential diagnosis of Alzheimer’s disease and frontotemporal dementia
Nguyen, H.-D., Clément, M., Planche, V., Mansencal, B., & Coupé, P. (2023) · Artificial Intelligence in Medicine · doi:10.1016/j.artmed.2023.102636 · Cited by 35
Wang, J., Redmond, S. J., Bertoux, M., Hodges, J. R., & Hornberger, M. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00119 · Cited by 35
Self-citationGossye, H., Van Broeckhoven, C., & Engelborghs, S. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00757 · Cited by 34
Frontotemporal dementia: Past, present, and future
Ulugut, H., & Pijnenburg, Y. A. L. (2023) · Alzheimer's & Dementia · doi:10.1002/alz.13363 · Cited by 33
Self-citationSaba, V., Premi, E., Cristillo, V., Gazzina, S., Palluzzi, F., Zanetti, O., Gasparotti, R., Padovani, A., Borroni, B., & Grassi, M. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00211 · Cited by 33
Huang, W.-C., Chang, M.-C., Wang, W.-F., & Jhang, K.-M. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2021.798315 · Cited by 34
“, 2017), and the International consensus criteria for behavioral variant FTD (Rascovsky et al., 2011) were used for the diagnosis of AD, VCI, Parkinson’s disease dementia (PDD), DLBs, and FTD, respectively.”
MethodInfluentialIdentifying bvFTD within the wide spectrum of late onset frontal lobe syndrome: a clinical approach
Krudop, W. A., Kerssens, C. J., Dols, A., Prins, N. D., Möller, C., Schouws, S., van der Flier, W. M., Scheltens, P., Sikkes, S., Stek, M. L., et al. (2015) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2015.04.002 · Cited by 33
Self-citationUniform data set language measures for bvFTD and PPA diagnosis and monitoring
Staffaroni, A. M., Weintraub, S., Rascovsky, K., Rankin, K. P., Taylor, J., Fields, J. A., Casaletto, K. B., Hillis, A. E., Lukic, S., Gorno‐Tempini, M. L., et al. (2021) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1002/dad2.12148 · Cited by 33
“(2) The ROC curve for the performance of the ratio of Phonemic:Semantic Fluency in classifying nfvPPA compared to lvPPA and svPPA.”
ResultSelf-citationFalgàs, N., Ruiz‐Peris, M., Pérez‐Millan, A., Sala‐Llonch, R., Antonell, A., Balasa, M., Borrego‐Écija, S., Ramos‐Campoy, O., Augé, J. M., Castellví, M., et al. (2020) · Human Brain Mapping · doi:10.1002/hbm.24925 · Cited by 32
Cheran, G., Silverman, H., Manoochehri, M., Goldman, J., Lee, S., Wu, L., Cines, S., Fallon, E., Kelly, B. D., Olszewska, D. A., et al. (2018) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2017-317263 · Cited by 32
Balasa, M., Gelpi, E., Martín, I., Antonell, A., Rey, M. J., Grau‐Rivera, O., Molinuevo, J. L., Sánchez‐Valle, R., Lladó, A., & Catalan collaborative Study Group for FTLD (2015) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12194 · Cited by 32
Shaw, A. D., Hughes, L. E., Moran, R., Coyle-Gilchrist, I., Rittman, T., & Rowe, J. B. (2021) · Cerebral Cortex · doi:10.1093/cercor/bhz024 · Cited by 30
Predictors of survival and progression in behavioural variant frontotemporal dementia
Agarwal, S., Ahmed, R. M., D'Mello, M., Foxe, D., Kaizik, C., Kiernan, M. C., Halliday, G. M., Piguet, O., & Hodges, J. R. (2019) · European Journal of Neurology · doi:10.1111/ene.13887 · Cited by 31
Self-citationHodges, J. R. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-129038 · Cited by 32
Self-citationProgress and challenges in the diagnosis of dementia: a critical review
Paraskevaidi, M., Martin-Hirsch, P. L., & Martin, F. L. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00007 · Cited by 31
Macfarlane, M. D., Jakabek, D., Walterfang, M., Vestberg, S., Velakoulis, D., Wilkes, F. A., Nilsson, C., van Westen, D., Looi, J. C. L., & Santillo, A. F. (2015) · PLOS ONE · doi:10.1371/journal.pone.0129692 · Cited by 31
Cognitive profiles discriminate between genetic variants of behavioral frontotemporal dementia
Poos, J. M., Jiskoot, L. C., Leijdesdorff, S. M. J., Seelaar, H., Panman, J. L., van der Ende, E. L., Mol, M. O., Meeter, L. H. H., Pijnenburg, Y. A. L., Donker Kaat, L., et al. (2020) · Journal of Neurology · doi:10.1007/s00415-020-09738-y · Cited by 31
Self-citationDetecting clinical change with the CDR-FTLD: differences between FTLD and AD dementia
Mioshi, E., Flanagan, E., & Knopman, D. (2017) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4556 · Cited by 29
“Of those, 603 patients were consecutively included if fulfilling the following criteria: for FTLD (Neary et al., 1998; Gorno-Tempini et al., 2011; Rascovsky et al., 2011) (n=350), diagnosis of behavioural variant FTD, primary progressive aphasia semantic variant or nonfluent variant and no…”
BackgroundSelf-citationPressman, P. S., Matlock, D., & Ducharme, S. (2021) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/appi.neuropsych.20090238 · Cited by 30
Johnen, A., Reul, S., Wiendl, H., Meuth, S. G., & Duning, T. (2018) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1016/j.dadm.2018.04.002 · Cited by 29
Novel CSF biomarkers to discriminate FTLD and its pathological subtypes
del Campo, M., Galimberti, D., Elias, N., Boonkamp, L., Pijnenburg, Y. A., van Swieten, J. C., Watts, K., Paciotti, S., Beccari, T., Hu, W., et al. (2018) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.629 · Cited by 30
Self-citationGonçalves, S. D. A. B., Caramelli, P., Mariano, L. I., Guimarães, H. C., Gambogi, L. B., Resende, E. D. P. F., Teixeira, A. L., & de Souza, L. C. (2020) · Brain Research · doi:10.1016/j.brainres.2020.146799 · Cited by 29
Cognitive Indicators of Preclinical Behavioral Variant Frontotemporal Dementia in MAPT Carriers
Cheran, G., Wu, L., Lee, S., Manoochehri, M., Cines, S., Fallon, E., Lynch, T., Heidebrink, J., Paulson, H., Goldman, J., et al. (2019) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617718001005 · Cited by 29
Recognition memory and divergent cognitive profiles in prodromal genetic frontotemporal dementia
Barker, M. S., Manoochehri, M., Rizer, S. J., Appleby, B. S., Brushaber, D., Dev, S. I., Devick, K. L., Dickerson, B. C., Fields, J. A., Foroud, T. M., et al. (2021) · Cortex · doi:10.1016/j.cortex.2021.03.006 · Cited by 29
Self-citationThe right temporal variant of frontotemporal dementia is not genetically sporadic: a case series
Ulugut Erkoyun, H., van der Lee, S. J., Nijmeijer, B., van Spaendonk, R., Nelissen, A., Scarioni, M., Dijkstra, A., Samancı, B., Gürvit, H., Yıldırım, Z., et al. (2021) · Journal of Alzheimer’s Disease · doi:10.3233/jad-201191 · Cited by 24
Self-citationPositive behaviour support in frontotemporal dementia: a pilot study
O’Connor, C. M. C., Mioshi, E., Kaizik, C., Fisher, A., Hornberger, M., & Piguet, O. (2021) · Neuropsychological Rehabilitation · doi:10.1080/09602011.2019.1707099 · Cited by 29
Self-citationUsing diffusion tensor imaging to detect cortical changes in fronto-temporal dementia subtypes
Torso, M., Bozzali, M., Cercignani, M., Jenkinson, M., & Chance, S. A. (2020) · Scientific Reports · doi:10.1038/s41598-020-68118-8 · Cited by 27
Bertoux, M., Flanagan, E. C., Hobbs, M., Ruiz-Tagle, A., Delgado, C., Miranda, M., Ibáñez, A., Slachevsky, A., & Hornberger, M. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-170771 · Cited by 28
Should I trust you? Learning and memory of social interactions in dementia
Wong, S., Irish, M., O’Callaghan, C., Kumfor, F., Savage, G., Hodges, J. R., Piguet, O., & Hornberger, M. (2017) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2017.08.016 · Cited by 28
Self-citationO'Connor, C. M., Clemson, L., Brodaty, H., Jeon, Y. H., Mioshi, E., & Gitlin, L. N. (2014) · International Psychogeriatrics · doi:10.1017/s1041610214000040 · Cited by 27
O'Connor, C. M., Clemson, L., Flanagan, E., Kaizik, C., Brodaty, H., Hodges, J. R., Piguet, O., & Mioshi, E. (2016) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000449283 · Cited by 27
Self-citationNeural effects of oxytocin and mimicry in frontotemporal dementia: A randomized crossover study
Oliver, L. D., Stewart, C., Coleman, K., Kryklywy, J. H., Bartha, R., Mitchell, D. G. V., & Finger, E. C. (2020) · Neurology · doi:10.1212/wnl.0000000000010933 · Cited by 26
Looking for measures of disease severity in the frontotemporal dementia continuum
Premi, E., Gualeni, V., Costa, P., Cosseddu, M., Gasparotti, R., Padovani, A., & Borroni, B. (2016) · Journal of Alzheimer’s Disease · doi:10.3233/jad-160178 · Cited by 26
Reus, L. M., Vijverberg, E. G., Tijms, B. M., Kate, M. T., Gossink, F., Krudop, W. A., Campo, M. D., Teunissen, C. E., Barkhof, F., van der Flier, W. M., et al. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2018.07.014 · Cited by 26
Self-citationReliability and Validity of Smartphone Cognitive Testing for Frontotemporal Lobar Degeneration
Staffaroni, A. M., Clark, A. L., Taylor, J. C., Heuer, H. W., Sanderson-Cimino, M., Wise, A. B., Dhanam, S., Cobigo, Y., Wolf, A., Manoochehri, M., et al. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.4266 · Cited by 28
Self-citationMRI data-driven algorithm for the diagnosis of behavioural variant frontotemporal dementia
Manera, A. L., Dadar, M., Van Swieten, J. C., Borroni, B., Sanchez-Valle, R., Moreno, F., Laforce Jr, R., Graff, C., Synofzik, M., Galimberti, D., et al. (2021) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2020-324106 · Cited by 23
Self-citationIn vivo exploration of synaptic projections in frontotemporal dementia
Salmon, E., Bahri, M. A., Plenevaux, A., Becker, G., Seret, A., Delhaye, E., Degueldre, C., Balteau, E., Lemaire, C., Luxen, A., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-95499-1 · Cited by 21
Accuracy of MRI classification algorithms in a tertiary memory center clinical routine cohort
Morin, A., Samper-Gonzalez, J., Bertrand, A., Ströer, S., Dormont, D., Mendes, A., Coupé, P., Ahdidan, J., Lévy, M., Samri, D., et al. (2020) · Journal of Alzheimer’s Disease · doi:10.3233/jad-190594 · Cited by 25
“Among neuroimaging biomarkers, MRI is the less invasive, most widely available, cost-effective, is systematically recommended in dementia, and can provide supportive criteria for many neurodegenerative conditions [2–4].”
Binney, R. J., Pankov, A., Marx, G., He, X., McKenna, F., Staffaroni, A. M., Kornak, J., Attygalle, S., Boxer, A. L., Schuff, N., et al. (2017) · Brain and Behavior · doi:10.1002/brb3.675 · Cited by 21
Self-citationToller, G., Mandelli, M. L., Cobigo, Y., Rosen, H. J., Kramer, J. H., Miller, B. L., Gorno-Tempini, M. L., & Rankin, K. P. (2022) · NeuroImage: Clinical · doi:10.1016/j.nicl.2022.102994 · Cited by 23
Self-citationKassubek, J., Müller, H.-P., Del Tredici, K., Hornberger, M., Schroeter, M. L., Müller, K., Anderl-Straub, S., Uttner, I., Grossman, M., Braak, H., et al. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00047 · Cited by 23
Self-citationPanza, F., Dibello, V., Sardone, R., Castellana, F., Zupo, R., Lampignano, L., Bortone, I., Stallone, R., Cirillo, N., Damiani, C., et al. (2023) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2023.2233892 · Cited by 22
Metadata
- Authors
- Rascovsky, K., Hodges, J. R., Knopman, D., Mendez, M. F., Kramer, J. H., Neuhaus, J., van Swieten, J. C., Seelaar, H., Dopper, E. G. P., Onyike, C. U., Hillis, A. E., Josephs, K. A., Boeve, B. F., Kertesz, A., Seeley, W. W., Rankin, K. P., Johnson, J. K., Gorno-Tempini, M.-L., Rosen, H., Prioleau-Latham, C. E., Lee, A., Kipps, C. M., Lillo, P., Piguet, O., Rohrer, J. D., Rossor, M. N., Warren, J. D., Fox, N. C., Galasko, D., Salmon, D. P., Black, S. E., Mesulam, M., Weintraub, S., Dickerson, B. C., Diehl-Schmid, J., Pasquier, F., Deramecourt, V., Lebert, F., Pijnenburg, Y., Chow, T. W., Manes, F., Grafman, J., Cappa, S. F., Freedman, M., Grossman, M., & Miller, B. L.
- Affiliations
- University of Pennsylvania (US)
- UNSW Sydney (AU)
- Mayo Clinic (US)
- University of California, Los Angeles (US)
- University of California, San Francisco (US)
- Erasmus MC (NL)
- Johns Hopkins University (US)
- Western University (CA)
- University Hospital Southampton NHS Foundation Trust (GB)
- UCL Queen Square Institute of Neurology (GB)
- University of California San Diego (US)
- Sunnybrook Health Science Centre (CA)
- Northwestern University (US)
- Université de Lille (FR)
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
- University of Toronto (CA)
- Favaloro University (AR)
- Kessler Foundation (US)
- Vita-Salute San Raffaele University (IT)
- ORCID
- Hodges, John R.
- Knopman, David
- Mendez, Mario F.
- Kramer, Joel H.
- Neuhaus, John
- Seelaar, Harro
- Dopper, Elise G. P.
- Onyike, Chiadi U.
- Hillis, Argye E.
- Josephs, Keith A.
- Boeve, Bradley F.
- Kertesz, Andrew
- Seeley, William W.
- Rankin, Katherine P.
- Johnson, Julene K.
- Kipps, Christopher M.
- Lillo, Patricia
- Piguet, Olivier
- Rohrer, Jonathan D.
- Rossor, Martin N.
- Warren, Jason D.
- Fox, Nick C.
- Galasko, Douglas
- Salmon, David P.
- Black, Sandra E.
- Mesulam, Marsel
- Pasquier, Florence
- Deramecourt, Vincent
- Lebert, Florence
- Pijnenburg, Yolande
- Chow, Tiffany W.
- Manes, Facundo
- Grafman, Jordan
- Cappa, Stefano F.
- Freedman, Morris
- Grossman, Murray
- Miller, Bruce L.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-08-02
- Volume
- 134
- Issue
- 9
- Pages
- 2456-2477
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- PMC
- PMC3170532
- OpenAlex
- W2128030851
- Cited by
- 5,221
- References
- 179
- Citations by year
- 2026: 333 · 2025: 445 · 2024: 486 · 2023: 427 · 2022: 456 · 2021: 460 · 2020: 459 · 2019: 355 · 2018: 338 · 2017: 325 · 2016: 293 · 2015: 276 · 2014: 225 · 2013: 208 · 2012: 115
- FWCI
- 122.40
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Brain (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- Iris (University of Trento) (submittedVersion, other-oa)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam) (submittedVersion)
- ePrints Soton (University of Southampton) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- mediaTUM (Technical University of Munich) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- U.S. Department of Veterans Affairs
- Alzheimer's Association
- Bristol-Myers Squibb (AG17586)
- Eli Lilly and Company (AG17586)
- Pfizer (AG17586)
- GlaxoSmithKline
- Sanofi
- Heart and Stroke Foundation of Canada
- Baxter International
- Wellcome Trust (091673)
- Canadian Stroke Network
- Myriad Genetics
- Alzheimer Society
- National Institute for Health and Care Research (NF-SI-0508-10123)
- University of Cambridge
- University of Oxford
- Elan
- Fonds Wetenschappelijk Onderzoek (P6/29)
- Eisai
- KU Leuven
- Vlaamse regering
- H. Lundbeck A/S
- National Institutes of Health (DC008552, AG016574, AG023501, AG019724, NS53488, AG06786, AG 17586, AG13854, AG15116, AG16574, AG32953)
- Canadian Institutes of Health Research (13129)
- Natural Sciences and Engineering Research Council of Canada
- National Institute on Aging (AG13854, P50‐AG16574, R01-AG15116, U01AG06786, RO1 AG15866, AG 16574, P01 AG-17586, U01AG006786, R01AG015116, P01AG017586, AG17586, R01AG034499, R01AG032306, AG019724, P01-AG32953, P01AG032953, P01AG019724, P50AG023501, P50AG016574)
- National Institute on Deafness and Other Communication Disorders (AG13854, DC008552, R01DC005375)
- National Institute of Neurological Disorders and Stroke (R01-NS44266, R01NS047691, R01NS044266)
- National Center for Research Resources (UL1RR025741)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Keywords
- behavioral variant frontotemporal dementia, diagnostic criteria, sensitivity, frontotemporal lobar degeneration, disinhibition, apathy, hyperorality, dysexecutive syndrome, functional disability, neuroimaging, diagnostic accuracy
- MeSH terms
- Aged, Behavior, Female, Humans, Male, Middle Aged, Neuropsychological Tests, Sensitivity and Specificity, Reproducibility of Results, Guidelines as Topic, Frontotemporal Dementia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
